Catalyst Wire Dossier Catalyst Wire Dossier

TA-7284

· Tanabe Pharma Corporation
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for TA-7284, covering 2014-04-28 to 2014-06-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment [Phase 1]

See pricing